迷幻诱导的神经可塑性:全面的审查和临床影响的讨论
Francesco Weiss1, Anna Magnesa1, Matteo Gambini1
1Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Via Roma 57, 56100 Pisa, Italy.
Brain sciences
|February 26, 2025
概括
迷幻药通过增强神经可塑性来改善心理健康,但它们的临床使用需要进一步研究好处和风险. 需要更多的研究来澄清心理治疗的适用性和适用性.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 迷幻药正在成为精神疾病的创新治疗方法.
- 由于安全性和有效性的担忧,它们的治疗用途仍然存在争议.
研究的目的:
- 审查心理药物诱导神经可塑性的临床前和临床证据.
- 评估心理治疗辅助疗法的潜在好处和风险.
主要方法:
- 在 MEDLINE/PubMed 和 Web of Science 上进行了系统的文献搜索.
- 包括的研究包括临床前和临床研究,提供原始数据.
- 经过严格的选择过程,70篇文章被选中.
主要成果:
- 临床前研究一致表明,迷幻药具有增强神经可塑性的特性.
- 临床证据,尽管存在挑战,似乎支持这些临床前发现.
- 神经可塑性效应和精神失灵体验之间的关系尚未完全理解.
结论:
- 迷幻药物显示出诱导神经可塑性的潜力,支持他们对心理健康治疗的调查.
- 进一步的研究至关重要,以界定特定的指示,禁忌,并优化迷幻疗法.
- 需要精准医学方法来澄清幻觉性心理塑原体的作用.
相关概念视频
Neuroplasticity
267
Neuroplasticity reflects the brain's remarkable capacity to adapt and evolve, responding dynamically to learning, experiences, or injury by reorganizing its neural circuitry. This reorganization involves creating new neural connections and refining old ones through a series of biological processes that contribute to the brain's lifelong development and adaptability.
267
Long-term Potentiation
54.6K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre- and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
54.6K
CNS Stimulants: Psychedelic Agents
116
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
116
Hallucinogens and Psychedelics
151
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
151
Altered States of Awareness
145
Altered states of consciousness represent significant deviations from one's normal mental state. These deviations can range from subtle changes in awareness to profound transformations in perception, thought processes, and sensory experiences. Altered states of consciousness can be triggered by various factors, including drug use, meditation, hypnosis, illness, or even intense fatigue.
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
145
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
361
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
361


